| 000 | 03421cam a22003614i 4500 | ||
|---|---|---|---|
| 999 |
_c2112 _d2112 |
||
| 001 | 13796179 | ||
| 005 | 20210816142758.0 | ||
| 008 | 041122s2004 nyua b 001 0 eng | ||
| 020 | _a0824748689 | ||
| 040 |
_aDLC _cDLC _dDLC _erda |
||
| 082 | 0 | 0 |
_a615.19 _222 _bF |
| 245 | 0 | 0 |
_aFreeze-drying/lyophilization of pharmaceutical and biological products / _cedited by Louis Rey, Joan C. May. |
| 250 | _aSecond edition. revised and expanded. | ||
| 264 | 1 |
_aNew York : _bMarcel Dekker, _c[2004] |
|
| 264 | 4 | _c©2004 | |
| 300 |
_avxvi, 613 pages : _billustrations ; _c24 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 490 | 1 |
_aDrugs and the pharmaceutical sciences ; _v137 |
|
| 505 | 0 | _aForeword -- Preface -- Contents -- Chapter 1: Glimpses into the Realm of Freeze-Drying: Fundamental Issues -- Chapter 2: Structural and Dynamic Properties of Bulk and Confined Water -- Chapter 3: Mechanisms of Protein Stabalization During Freeze-Drying and Storage: The Relative Importance of Thermodynamic Stabalization and Glassy State Relaxation Dynamics -- Chapter 4: Freezing and Annealing Phenomena in Lyophilization -- Chapter 5: Freezing- and Drying-Induced Pertubations of Protien Structure and Mechanisms of Protein Protection by Stabilizing Additives -- Chapter 6: Molecular Mobility of Freeze-Dried Formulations as Determined by NMR Relaxation, and it's Effect on Storage Stability -- Chapter 7: Formulation Characterization -- Chapter 8: Practical Aspects of Freeze-Drying of Pharmaceutical and Biological Products Using Non-Aqueous Co-Solvent Systems -- Chapter 9: Cosure and Container Considerations in Lyophilization -- Chapter 10: Advanced Glassware for Freeze-Drying -- Chapter 11: Critical Steps in the Preperation of Elastomeric Closures for Biopharmaceutical Freeze-Dried Products -- Chapter 12: Development of a New Concept for Bulk Freeze-Drying: LYOGUARD Freeze-Dry Packaging -- Chapter 13: Regulatory Control of Freeze-Dried Products: Importance and Evaluation of Residual Moisture -- Chapter 14: Freeze-Drying of Biological Standards -- Chapter 15: Industrial Freeze-Drying for Pharmaceutical Applications -- Chapter 16: Development of Process Data in a Pilot Plant Transferable to Production -- Chapter 17: Technical Procedures for Operation of Cleaning-in-Place/Sterilization-in-place Process for Production Freeze-Drying Equipment -- Chapter 18: Global Validation of Freeze-Drying Cycle Parameters by Using Integral HFT Systems -- Chapter 19: Lyophilizer Qualification: Some Practical Advice. Chapter 20: Lyophilization Process Validation -- Chapter 21: A New Development: Irradiation of Freeze-Dried Vaccine and Other Select Biological Products -- Chapter 22: Some Leading Edge Prospects in Lyophilization -- Index. | |
| 650 | 0 | _aFreeze-drying. | |
| 650 | 0 |
_aDrugs _xDrying. |
|
| 650 | 0 |
_aBiological products _xDrying. |
|
| 700 | 1 |
_aRey, Louis, _98632 _eeditor. |
|
| 700 | 1 |
_aMay, Joan C., _q(Joan Christine) _98633 _eeditor. |
|
| 830 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 137. _98634 |
|
| 856 |
_3Abstract _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/1546 |
||
| 906 |
_a7 _bcbc _corigcop _d2 _encip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||